» Articles » PMID: 15128832

The Functional Profile of Primary Human Antiviral CD8+ T Cell Effector Activity is Dictated by Cognate Peptide Concentration

Overview
Journal J Immunol
Date 2004 May 7
PMID 15128832
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Antiviral CD8(+) T cells can elaborate at least two effector functions, cytokine production and cytotoxicity. Which effector function is elaborated can determine whether the CD8(+) T cell response is primarily inflammatory (cytokine producing) or antiviral (cytotoxic). In this study we demonstrate that cytotoxicity can be triggered at peptide concentrations 10- to 100-fold less than those required for cytokine production in primary HIV- and CMV-specific human CD8(+) T cells. Cytolytic granule exocytosis occurs at peptide concentrations insufficient to cause substantial TCR down-regulation, providing a mechanism by which a CD8(+) T cell could engage and lyse multiple target cells. TCR sequence analysis of virus-specific cells shows that individual T cell clones can degranulate or degranulate and produce cytokine depending on the Ag concentration, indicating that response heterogeneity exists within individual CD8(+) T cell clonotypes. Thus, antiviral CD8(+) T cell effector function is determined primarily by Ag concentration and is not an inherent characteristic of a virus-specific CD8(+) T cell clonotype or the virus to which the response is generated. The inherent ability of viruses to induce high or low Ag states may be the primary determinant of the cytokine vs cytolytic nature of the virus-specific CD8(+) T cell response.

Citing Articles

Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products.

Durkee-Shock J, Lazarski C, Jensen-Wachspress M, Zhang A, Son A, Kankate V Mol Ther Methods Clin Dev. 2022; 25:439-447.

PMID: 35506060 PMC: 9050197. DOI: 10.1016/j.omtm.2022.04.013.


Epitope length variants balance protective immune responses and viral escape in HIV-1 infection.

Pymm P, Tenzer S, Wee E, Weimershaus M, Burgevin A, Kollnberger S Cell Rep. 2022; 38(9):110449.

PMID: 35235807 PMC: 9631117. DOI: 10.1016/j.celrep.2022.110449.


The Dynamic Entropy of Tumor Immune Infiltrates: The Impact of Recirculation, Antigen-Specific Interactions, and Retention on T Cells in Tumors.

Blair T, Alice A, Zebertavage L, Crittenden M, Gough M Front Oncol. 2021; 11:653625.

PMID: 33968757 PMC: 8101411. DOI: 10.3389/fonc.2021.653625.


Constant regulation for stable CD8 T-cell functional avidity and its possible implications for cancer immunotherapy.

Gilfillan C, Hebeisen M, Rufer N, Speiser D Eur J Immunol. 2021; 51(6):1348-1360.

PMID: 33704770 PMC: 8252569. DOI: 10.1002/eji.202049016.


A Strategy to Elicit M2e-Specific Antibodies Using a Recombinant H7N9 Live Attenuated Influenza Vaccine Expressing Multiple M2e Tandem Repeats.

Mezhenskaya D, Isakova-Sivak I, Kotomina T, Matyushenko V, Kim M, Bhatnagar N Biomedicines. 2021; 9(2).

PMID: 33535408 PMC: 7912525. DOI: 10.3390/biomedicines9020133.